Ludmila Prudkin
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Revisiting methylprednisolone aceponate: efficacy, safety and current positioning.
Journal: Drugs in context
Published: May 14, 2026
The impact of the six pillars of lifestyle medicine on the biology of skin aging.
Journal: Frontiers in aging
Published: March 03, 2026
An Assessment of the Antifungal Efficacy of a Novel Topical Onychomycosis Treatment Using Human Nail and Skin Infection Models.
Journal: Journal of fungi (Basel, Switzerland)
Published: March 17, 2025
Pollution, a Relevant Exposome Factor in Skin Aging and the Role of Multi-benefit Photoprotection.
Journal: Actas dermo-sifiliograficas
Published: August 20, 2024
The exposome impact on hair health: non-pharmacological management. Part II⋆.
Journal: Anais brasileiros de dermatologia
Published: June 11, 2024
The exposome impact on hair health: etiology, pathogenesis and clinical features ‒ Part I.
Journal: Anais brasileiros de dermatologia
Published: May 19, 2024
Use of Topical Corticosteroids in the Treatment of Noninfectious Inflammatory Dermatoses of the Scalp: A Survey of Practicing Dermatologists and Dermatology Residents Using Delphi Methodology.
Journal: Clinical, cosmetic and investigational dermatology
Published: November 03, 2023
Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Journal: Nature
Published: January 18, 2018
mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Journal: Nature
Published: September 12, 2016
Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 08, 2015
PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 07, 2015
Last Updated: 09/26/2026